Please wait a minute...
文章检索
预防医学  2023, Vol. 35 Issue (1): 57-60    DOI: 10.19485/j.cnki.issn2096-5087.2023.01.013
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
衢州市肺结核合并糖尿病病例特征分析
张雅婷1, 郝晓刚2, 王炜2, 焦仕林2, 方春福2, 张幸2
1.浙江中医药大学公共卫生学院,浙江 杭州 310000;
2.衢州市疾病预防控制中心,浙江 衢州 324000
Characteristics of pulmonary tuberculosis patients complicated by diabetes mellitus in Quzhou City
ZHANG Yating1, HAO Xiaogang2, WANG Wei2, JIAO Shilin2, FANG Chunfu2, ZHANG Xing2
1. School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310000, China;
2. Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang 324000, China
全文: PDF(801 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解衢州市肺结核合并糖尿病病例特征,为肺结核合并糖尿病防控工作提供参考。方法 通过中国疾病预防控制信息系统结核病管理信息系统收集2016—2020年衢州市肺结核病例资料,描述性分析肺结核合并糖尿病病例的人口学和诊疗特征,并与单纯肺结核病例进行比较。结果 2016—2020年衢州市肺结核合并糖尿病发病率为6.79/10万~9.27/10万,年递增率为8.09%。肺结核合并糖尿病病例中,男性674例,占76.94%;≥60岁620例,占70.78%;城镇居民564例,占64.38%;农民619例,占70.66%;就诊延迟537例,占61.30%;初治802例,占91.55%;病原学阳性547例,占62.44%;利福平耐药11例,占1.26%;2个月末痰涂片阴转695例,占79.34%;治疗成功783例,占89.38%。肺结核合并糖尿病病例中男性、≥60岁、城镇居民、农民、就诊延迟、病原学阳性和利福平耐药的比例高于单纯肺结核病例,2个月末痰涂片阴转的比例低于单纯肺结核病例(均P<0.05)。结论 2016—2020年衢州市肺结核合并糖尿病发病率呈上升趋势,以老年男性为主,就诊延迟、病原学阳性和利福平耐药比例均高于单纯肺结核病例。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
张雅婷
郝晓刚
王炜
焦仕林
方春福
张幸
关键词 肺结核糖尿病合并症    
AbstractObjective To analyze the epidemiological and clinical characteristics of pulmonary tuberculosis patients complicated by diabetes mellitus (PTB-DM), so as to provide insights into PTB-DM control. Methods The data pertaining to PTB cases in Quzhou City from 2016 to 2020 were extracted from Tuberculosis Information Management System of Chinese Disease Prevention and Control Information System. The demographic features, diagnosis and treatment of PTB-DM patients were descriptively analyzed, and compared with PTB patients. Results The incidence of PTB-DM was 6.79/105 to 9.27/105 in Quzhou City from 2016 to 2020, with an annual increase rate of 8.09%. Among all PTB-DM patients, there were 674 men (76.94%), 620 cases at ages of 60 years and older (70.78%), 564 cases living in urban areas (64.38%), 619 farmers (70.66%), 537 cases with delay in healthcare-seeking (61.30%), 802 treatment-naïve cases (91.55%), 547 cases positive for pathogenic tests (62.44%), 11 cases with rifampicin resistance (1.26%), 695 cases with negative conversion of sputum smears 2 months post-treatment (79.34%), and 783 cases with successful treatment (89.38%). The proportions of men, ages of 60 years and older, living in urban areas, farmers, delay in healthcare-seeking, positive pathogenic tests and rifampicin resistance were significantly higher among PTB-DM patients than among PTB patients, and the negative conversion rate of sputum smears 2 months post-treatment was significantly lower among PTB-DM patients than among PTB patients (all P<0.05). Conclusions The incidence of PTB-DM increased year by year in Quzhou City from 2016 to 2020, and PTB-DM cases were predominantly found among elderly men. The proportion of delay in healthcare-seeking, positive pathogenic tests and rifampicin resistance was higher among PTB-DM patients than among PTB patients.
Key wordspulmonary tuberculosis    diabetes mellitus    comorbidity
收稿日期: 2022-09-22      修回日期: 2022-10-24      出版日期: 2023-01-10
中图分类号:  R521  
  R587.1  
基金资助:衢州市指导性科技攻关项目(2019119); 浙江省传染病疫苗与预防控制研究重点实验室开放基金(2022-6)
通信作者: 方春福,E-mail:541190943@qq.com   
作者简介: 张雅婷,硕士研究生在读
引用本文:   
张雅婷, 郝晓刚, 王炜, 焦仕林, 方春福, 张幸. 衢州市肺结核合并糖尿病病例特征分析[J]. 预防医学, 2023, 35(1): 57-60.
ZHANG Yating, HAO Xiaogang, WANG Wei, JIAO Shilin, FANG Chunfu, ZHANG Xing. Characteristics of pulmonary tuberculosis patients complicated by diabetes mellitus in Quzhou City. Preventive Medicine, 2023, 35(1): 57-60.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2023.01.013      或      http://www.zjyfyxzz.com/CN/Y2023/V35/I1/57
[1] World Health Organization.Global Tuberculosis Report 2021[R].Geneva:World Health Organization,2021.
[2] SUN H,SAEEDI P,KARURANGA S,et al.IDF diabetes atlas:global,regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J/OL].Diabetes Res Clin Pract,2022,183(2022-01-01)[2022-10-24].http://doi.org/110.1016/j.diabres.2021.109119.
[3] AL-RIFAI R H,PEARSON F,CRITCHLEY J A,et al.Association between diabetes mellitus and active tuberculosis:a systematic review and meta-analysis[J/OL].PLoS One,2017,12(11)(2017-09-21)[2022-10-24].http://doi.org/10.1371/journal.pone.0187967.
[4] 高见. HIV或2型糖尿病合并肺结核与单纯肺结核临床特征的研究[D].大连:大连医科大学,2017.
[5] SINHA P,MOLL A P,BROOKS R P,et al.Synergism between diabetes and human immunodeficiency virus in increasing the risk of tuberculosis[J].Int J Tuberc Lung Dis,2018,22(7):793-799.
[6] 中华人民共和国国家卫生和计划生育委员会.结核病分类:WS 196—2017[S].2018.
[7] 中华人民共和国国家卫生和计划生育委员会.肺结核诊断:WS 288—2017[S].2018.
[8] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志,2021,13(4):315-409.
[9] 姚琳,顾斌斌,王霞芳,等.苏州地区2011年—2017年间9 528例肺结核患者合并症的原因分析及其分布趋势[J].抗感染药学,2019,16(2):258-261.
[10] 汪清雅,庞艳,李建琼,等.2014—2018年重庆市肺结核合并糖尿病病例特征分析[J].预防医学,2021,33(5):476-478,483.
[11] PODELL B K,ACKART D F,OBREGON-HENAO A,et al.Increased severity of tuberculosis in Guinea pigs with type 2 diabetes:a model of diabetes-tuberculosis comorbidity[J].Am J Pathol,2014,184(4):1104-1118.
[12] 张海清,李莉,吴云亮,等.2016—2020年徐州市肺结核合并糖尿病患者流行病学特征及转归分析[J].江苏预防医学,2021,32(5):597-598.
[13] 王黎霞,成诗明,陈明亭,等.2010年全国第五次结核病流行病学抽样调查报告[J].中国防痨杂志,2012,34(8):485-508.
[14] 李晓蓉,庞学文.社区糖尿病患者结核病筛查的可行性分析[J].华西医学,2021,36(10):1465-1468.
[15] LÖNNROTH K,ROGLIC G,HARRIES A D.Improving tuberculosis prevention and care through addressing the global diabetes epidemic:from evidence to policy and practice[J].Lancet Diabetes Endocrinol,2014,2(9):730-739.
[16] RESTREPO B I,SCHLESINGER L S.Impact of diabetes on the natural history of tuberculosis[J].Diabetes Res Clin Pract,2014,106(2):191-199.
[17] LEE P,FU H,LAI T C,et al.Glycemic control and the risk of tuberculosis:a cohort study[J/OL].PLoS Med,2016,13(8)(2016-08-09)[2022-10-24].http://doi.org/10.1371/journal.pmed.1002072.
[1] 张铁威, 张艳, 刘冰, 秦康, 李标, 徐珏. 2013—2021年杭州市糖尿病死亡及疾病负担分析[J]. 预防医学, 2023, 35(9): 752-756.
[2] 王远航, 胡洁, 葛锐, 富小飞, 亓云鹏. 嘉兴市结核分枝杆菌耐药情况分析[J]. 预防医学, 2023, 35(8): 705-709.
[3] 黎燕, 雷梦婷, 王燧, 殷淑娇, 章存瑞, 李清春. 一起涉及多所学校的肺结核聚集性疫情调查[J]. 预防医学, 2023, 35(7): 607-610.
[4] 张丹平, 徐玲妙. 糖尿病与血管性痴呆发病的关联、病理机制及防治策略研究[J]. 预防医学, 2023, 35(7): 582-586.
[5] 柏旭, 苏洁, 李凤, 徐倩, 沈源, 肖凌凤. 我国成人糖尿病视网膜病变影响因素的Meta分析[J]. 预防医学, 2023, 35(7): 595-601.
[6] 聂东梅, 李一鹏, 黄妍. 2012—2021年江门市4类慢性病早死概率分析[J]. 预防医学, 2023, 35(7): 602-606.
[7] 丁承辉, 吴萃, 薛琨, 励晓红, 万金豹, 陈秋艳, 朱潇翔. 宝山区糖尿病高危人群筛查结果分析[J]. 预防医学, 2023, 35(6): 509-513.
[8] 沈放如, 杨可, 刘厚璞, 朱家豪, 李迎君. 新生儿出生体重与母亲2型糖尿病关联的双向孟德尔随机化研究[J]. 预防医学, 2023, 35(5): 384-387,409.
[9] 马奕竹, 赵效国, 朱启英, 马依拉·买买提, 张环美, 苑晓琳, 李莉. 孕期膳食模式与妊娠糖尿病的关联研究[J]. 预防医学, 2023, 35(4): 286-290.
[10] 刘国志, 袁空军, 庄蔚, 周光清. 国内外城市社区2型糖尿病健康管理模式比较[J]. 预防医学, 2023, 35(3): 262-266.
[11] 顾逸藜, 孙晓燕, 谢臻蔚. 女性糖尿病与压力性尿失禁研究进展[J]. 预防医学, 2023, 35(2): 130-133.
[12] 谢睿, 胡菊莲, 喻喆. 妊娠糖尿病患者生活质量的影响因素研究[J]. 预防医学, 2023, 35(2): 162-165.
[13] 李娜娜, 张师静, 陈巧敏, 栗浩然, 王雅莉. 孕前体质指数与妊娠糖尿病的剂量-反应关系[J]. 预防医学, 2023, 35(10): 829-833.
[14] 陈可, 李锦成, 虞浩, 竺丽梅, 刘巧. 扬州市65岁及以上老年人群肺结核流行特征分析[J]. 预防医学, 2023, 35(10): 877-880.
[15] 姜佳佳, 李峰, 房冬冬, 尤文君, 王伟伟. 2型糖尿病患者非增殖型糖尿病性视网膜病变的影响因素分析[J]. 预防医学, 2023, 35(1): 17-20.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed